Introduction to pandemic influenza / ed. by Jonathan Van-Tam ...
Pandemic influenza is an emerging pathogen that has serious public health consequences. Following recent avian and swine influenza outbreaks, preparedness against pandemic influenza on national and international scales is of vital importance. This book includes 29 chapters covering the following topics: epidemiology and clinical features of interpandemic influenza and pandemic influenza A(H1N1)pdm09; surveillance and pandemic requirements; basic influenza virology and immunology; influenza in birds and mammals, including humans; history of influenza pandemics; transmission and infection control issues; pandemic preparedness; emergency preparedness and business continuity planning; role of exercises in pandemic preparedness; local health services responses; bio-mathematical modelling; pharmaceutical interventions (antiviral drugs and vaccines); national and international public health measures; port health and international health regulations; socioeconomic impact; ethical issues related to pandemic preparedness and response; pandemic communication (e.g. mass media, internet, social media); and case studies of pandemic experience, response, preparedness and planning in Mexico, Chile, New Zealand, Former Soviet Union, Africa, Denmark, South East Asia, North America (Canada and USA) and Saudi Arabia. This book is intended for students in virology, epidemiology, infectious diseases, public health and medical sciences, and for all those involved in pandemic preparedness..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
Wallingford: CABI ; 2012 |
| Ausgabe: |
2. ed. |
| Reihe: |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Van-Tam, Jonathan [HerausgeberIn] |
|---|
| Links: |
doi.org [lizenzpflichtig] |
|---|
| ISBN: |
|---|
| Anmerkungen: |
Includes bibliographical references and index |
|---|
| Umfang: |
Online-Ressource |
|---|
| doi: |
10.1079/9781845938567.0000 |
|---|---|
| Weitere IDs: |
9781845936259 |
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1651804745 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 1651804745 | ||
| 003 | DE-627 | ||
| 005 | 20230918205851.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 121025s2012 xxk|||||o 00| ||eng c | ||
| 020 | |a 9781845938567 |9 978-1-84593-856-7 | ||
| 024 | 3 | |a 9781845936259 | |
| 024 | 7 | |a 10.1079/9781845938567.0000 |2 doi | |
| 035 | |a (DE-627)1651804745 | ||
| 035 | |a (DE-576)37260739X | ||
| 035 | |a (DE-599)BSZ37260739X | ||
| 035 | |a (OCoLC)985096627 | ||
| 035 | |a (OCoLC)985096627 | ||
| 035 | |a (EBP)061230847 | ||
| 035 | |a (CABI)10.1079/9781845938567.0000 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 044 | |c XA-GB | ||
| 050 | 0 | |a RA644.I6 | |
| 082 | 0 | |a 614.518 | |
| 082 | 0 | |a 614.5/18 |2 23 | |
| 245 | 1 | 0 | |a Introduction to pandemic influenza |c ed. by Jonathan Van-Tam ... |
| 250 | |a 2. ed. | ||
| 264 | 1 | |a Wallingford |b CABI |c 2012 | |
| 300 | |a Online-Ressource | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Modular texts | |
| 500 | |a Includes bibliographical references and index | ||
| 506 | |a Access limited to subscribing institution. | ||
| 520 | |a Pandemic influenza is an emerging pathogen that has serious public health consequences. Following recent avian and swine influenza outbreaks, preparedness against pandemic influenza on national and international scales is of vital importance. This book includes 29 chapters covering the following topics: epidemiology and clinical features of interpandemic influenza and pandemic influenza A(H1N1)pdm09; surveillance and pandemic requirements; basic influenza virology and immunology; influenza in birds and mammals, including humans; history of influenza pandemics; transmission and infection control issues; pandemic preparedness; emergency preparedness and business continuity planning; role of exercises in pandemic preparedness; local health services responses; bio-mathematical modelling; pharmaceutical interventions (antiviral drugs and vaccines); national and international public health measures; port health and international health regulations; socioeconomic impact; ethical issues related to pandemic preparedness and response; pandemic communication (e.g. mass media, internet, social media); and case studies of pandemic experience, response, preparedness and planning in Mexico, Chile, New Zealand, Former Soviet Union, Africa, Denmark, South East Asia, North America (Canada and USA) and Saudi Arabia. This book is intended for students in virology, epidemiology, infectious diseases, public health and medical sciences, and for all those involved in pandemic preparedness. | ||
| 650 | 0 | |a Influenza |x Epidemiology | |
| 650 | 0 | |a Influenza |x Prevention | |
| 650 | 0 | |a eukaryotes | |
| 650 | 0 | |a Asia | |
| 650 | 0 | |a Denmark | |
| 650 | 0 | |a mammals | |
| 650 | 0 | |a news media | |
| 650 | 0 | |a public health | |
| 650 | 0 | |a Middle East | |
| 650 | 0 | |a vertebrates | |
| 650 | 0 | |a chemotherapy | |
| 650 | 0 | |a Developing Countries | |
| 650 | 0 | |a influenza A | |
| 650 | 0 | |a Homo | |
| 650 | 0 | |a human diseases | |
| 650 | 0 | |a emergencies | |
| 650 | 0 | |a Influenza A virus | |
| 650 | 0 | |a immunology | |
| 650 | 0 | |a North America | |
| 650 | 0 | |a Andean Group | |
| 650 | 0 | |a virology | |
| 650 | 0 | |a RNA Viruses | |
| 650 | 0 | |a America | |
| 650 | 0 | |a Northern Europe | |
| 650 | 0 | |a negative-sense ssRNA Viruses | |
| 650 | 0 | |a history | |
| 650 | 0 | |a Scandinavia | |
| 650 | 0 | |a communication | |
| 650 | 0 | |a Union of Soviet Socialist Republics | |
| 650 | 0 | |a internet | |
| 650 | 0 | |a vaccination | |
| 650 | 0 | |a epidemiology | |
| 650 | 0 | |a South America | |
| 650 | 0 | |a Developed Countries | |
| 650 | 0 | |a antiviral agents | |
| 650 | 0 | |a New Zealand | |
| 650 | 0 | |a Orthomyxoviridae | |
| 650 | 0 | |a socioeconomic aspects | |
| 650 | 0 | |a social impact | |
| 650 | 0 | |a animals | |
| 650 | 0 | |a Chile | |
| 650 | 0 | |a planning | |
| 650 | 0 | |a international travel | |
| 650 | 0 | |a Oceania | |
| 650 | 0 | |a primates | |
| 650 | 0 | |a Saudi Arabia | |
| 650 | 0 | |a clinical picture | |
| 650 | 0 | |a influenza | |
| 650 | 0 | |a economic impact | |
| 650 | 0 | |a birds | |
| 650 | 0 | |a USSR | |
| 650 | 0 | |a Nordic Countries | |
| 650 | 0 | |a Commonwealth of Nations | |
| 650 | 0 | |a H1N1 subtype influenza A virus | |
| 650 | 0 | |a USA | |
| 650 | 0 | |a vaccines | |
| 650 | 0 | |a ssRNA Viruses | |
| 650 | 0 | |a health services | |
| 650 | 0 | |a European Union Countries | |
| 650 | 0 | |a clinical aspects | |
| 650 | 0 | |a pandemics | |
| 650 | 0 | |a Southeast Asia | |
| 650 | 0 | |a surveillance | |
| 650 | 0 | |a Latin America | |
| 650 | 0 | |a Influenzavirus A | |
| 650 | 0 | |a APEC countries | |
| 650 | 0 | |a Mexico | |
| 650 | 0 | |a man | |
| 650 | 0 | |a rules | |
| 650 | 0 | |a regulations | |
| 650 | 0 | |a West Asia | |
| 650 | 0 | |a Africa | |
| 650 | 0 | |a Chordata | |
| 650 | 0 | |a Canada | |
| 650 | 0 | |a immune sensitization | |
| 650 | 0 | |a influenza viruses | |
| 650 | 0 | |a Australasia | |
| 650 | 0 | |a Hominidae | |
| 650 | 0 | |a immunization | |
| 650 | 0 | |a epidemics | |
| 650 | 0 | |a antivirals | |
| 650 | 0 | |a disease transmission | |
| 650 | 0 | |a infection control | |
| 650 | 0 | |a drug therapy | |
| 650 | 0 | |a zoonoses | |
| 650 | 0 | |a South East Asia | |
| 650 | 0 | |a viruses | |
| 650 | 0 | |a OECD Countries | |
| 650 | 0 | |a socioeconomics | |
| 650 | 0 | |a Europe | |
| 650 | 0 | |a flu | |
| 650 | 0 | |a disease control | |
| 650 | 0 | |a United States of America | |
| 650 | 0 | |a mass media | |
| 650 | 0 | |a ethics | |
| 650 | 0 | |a Threshold Countries | |
| 650 | 0 | |a case studies | |
| 650 | 0 | |a mathematical models | |
| 650 | 0 | |a zoonotic infections | |
| 650 | 0 | |a social media | |
| 650 | 4 | |a Influenza ; Prevention | |
| 650 | 4 | |a Communicable diseases | |
| 650 | 4 | |a Influenza, Human ; epidemiology | |
| 650 | 4 | |a Communicable Disease Control | |
| 650 | 4 | |a Influenza, Human ; prevention & control | |
| 650 | 4 | |a Pandemics ; prevention & control | |
| 650 | 4 | |a Laws and Regulations | |
| 650 | 4 | |a Health Economics, (New March 2000) | |
| 650 | 4 | |a Pesticides and Drugs; Control, (New March 2000) | |
| 650 | 4 | |a Host Resistance and Immunity | |
| 650 | 4 | |a Prion, Viral, Bacterial and Fungal Pathogens of Animals, (New March 2000) | |
| 650 | 4 | |a Health Services | |
| 650 | 4 | |a Communication and Mass Media | |
| 650 | 4 | |a Social Psychology and Social Anthropology, (New March 2000) | |
| 650 | 4 | |a Tourism and Travel | |
| 650 | 4 | |a Human Immunology and Allergology, (New March 2000) | |
| 650 | 4 | |a Prion, Viral, Bacterial and Fungal Pathogens of Humans, (New March 2000) | |
| 650 | 4 | |a Pathogens, Parasites and Infectious Diseases (Wild Animals), (New March 2000) | |
| 650 | 4 | |a Mathematics and Statistics | |
| 650 | 4 | |a Microbiology (General) | |
| 650 | 4 | |a Antiviral agents | |
| 650 | 4 | |a Case studies | |
| 650 | 4 | |a Clinical aspects | |
| 650 | 4 | |a Communication | |
| 650 | 4 | |a Disease control | |
| 650 | 4 | |a Disease transmission | |
| 650 | 4 | |a Drug therapy | |
| 650 | 4 | |a Economic impact | |
| 650 | 4 | |a Emergencies | |
| 650 | 4 | |a Epidemics | |
| 650 | 4 | |a Epidemiology | |
| 650 | 4 | |a Ethics | |
| 650 | 4 | |a Health services | |
| 650 | 4 | |a History | |
| 650 | 4 | |a Human diseases | |
| 650 | 4 | |a Immunization | |
| 650 | 4 | |a Immunology | |
| 650 | 4 | |a Infection control | |
| 650 | 4 | |a Influenza | |
| 650 | 4 | |a Influenza A | |
| 650 | 4 | |a Influenza viruses | |
| 650 | 4 | |a International travel | |
| 650 | 4 | |a Internet | |
| 650 | 4 | |a Mass media | |
| 650 | 4 | |a Mathematical models | |
| 650 | 4 | |a Planning | |
| 650 | 4 | |a Public health | |
| 650 | 4 | |a Regulations | |
| 650 | 4 | |a Social impact | |
| 650 | 4 | |a Social media | |
| 650 | 4 | |a Socioeconomics | |
| 650 | 4 | |a Surveillance | |
| 650 | 4 | |a Vaccination | |
| 650 | 4 | |a Vaccines | |
| 650 | 4 | |a Virology | |
| 650 | 4 | |a Zoonoses | |
| 650 | 4 | |a DD500 | |
| 650 | 4 | |a EE118 | |
| 650 | 4 | |a HH405 | |
| 650 | 4 | |a HH600 | |
| 650 | 4 | |a LL821 | |
| 650 | 4 | |a UU350 | |
| 650 | 4 | |a UU360 | |
| 650 | 4 | |a UU485 | |
| 650 | 4 | |a UU700 | |
| 650 | 4 | |a VV055 | |
| 650 | 4 | |a VV210 | |
| 650 | 4 | |a YY700 | |
| 650 | 4 | |a ZZ100 | |
| 650 | 4 | |a ZZ390 | |
| 655 | 0 | |a Electronic books | |
| 700 | 1 | |a Van-Tam, Jonathan |e hrsg |4 edt | |
| 776 | 1 | |z 9781845938567 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781845938567 |
| 856 | 4 | 0 | |u https://doi.org/10.1079/9781845938567.0000 |m X:CABI |x Resolving-System |z lizenzpflichtig |
| 856 | 4 | 0 | |u https://www.cabidigitallibrary.org/doi/book/10.1079/9781845938567.0000 |m X:CABI |x Verlag |z lizenzpflichtig |
| 912 | |a ZDB-91-CABI1 |b 2012 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a ISIL_DE-3 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a GBV_ILN_252 | ||
| 912 | |a GBV_ILN_252_i00e | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a ISIL_DE-517 | ||
| 912 | |a GBV_ILN_2026 | ||
| 912 | |a ISIL_DE-100 | ||
| 951 | |a BO | ||
| 953 | |2 045F |a 614.518 | ||
| 953 | |2 045F |a 614.5/18 | ||
| 980 | |2 65 |1 01 |x 0003 |b 3909037909 |h CAB-Archive |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y k3o |z 14-04-21 | ||
| 980 | |2 252 |1 01 |x 4252 |b 3851217136 |c 00 |f BMEL |d Online-Ressource |e --%%-- |j --%%-- |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y zi00e |z 11-02-21 | ||
| 980 | |2 285 |1 01 |x 0517 |b 4377564633 |h OLR-CAB-TEST |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y z |z 18-09-23 | ||
| 980 | |2 2026 |1 01 |x DE-100 |b 3353860533 |c 00 |f --%%-- |d --%%-- |e --%%-- |j en |y l01 |z 25-10-12 | ||
| 981 | |2 65 |1 01 |x 0003 |r https://doi.org/10.1079/9781845938567.0000 | ||
| 981 | |2 252 |1 01 |x 4252 |y E-books (CABI) |r https://doi.org/10.1079/9781845938567.0000 |z ZZ | ||
| 981 | |2 285 |1 01 |x 0517 |r https://doi.org/10.1079/9781845938567.0000 | ||
| 981 | |2 2026 |1 01 |x DE-100 |r https://doi.org/10.1079/9781845938567.0000 | ||
| 982 | |2 252 |1 01 |x 4252 |8 00 |a Elektronisches Buch | ||
| 995 | |2 65 |1 01 |x 0003 |a CAB-Archive | ||
| 995 | |2 285 |1 01 |x 0517 |a OLR-CAB-TEST | ||